Hicham Lahlou

1.0k total citations
14 papers, 843 citations indexed

About

Hicham Lahlou is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Hicham Lahlou has authored 14 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Hicham Lahlou's work include Neuroendocrine Tumor Research Advances (5 papers), Neuroblastoma Research and Treatments (3 papers) and Cell Adhesion Molecules Research (3 papers). Hicham Lahlou is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Neuroblastoma Research and Treatments (3 papers) and Cell Adhesion Molecules Research (3 papers). Hicham Lahlou collaborates with scholars based in France, Canada and United Kingdom. Hicham Lahlou's co-authors include William J. Muller, Christiane Susini, Stéphane Pyronnet, Virginie Sanguin‐Gendreau, Corinne Bousquet, Margaret C. Frame, Julie Guillermet‐Guibert, Bernard Knibiehler, Honoré Mazarguil and Yves Audigier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Hicham Lahlou

14 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hicham Lahlou France 13 335 263 204 187 163 14 843
Jingzhen Yuan United States 17 603 1.8× 205 0.8× 100 0.5× 43 0.2× 305 1.9× 24 962
Hans Baumeister Germany 13 359 1.1× 132 0.5× 139 0.7× 51 0.3× 74 0.5× 24 774
Riccardo Chiusaroli United States 17 520 1.6× 244 0.9× 41 0.2× 157 0.8× 45 0.3× 22 898
Angela Russo United States 20 537 1.6× 142 0.5× 44 0.2× 53 0.3× 37 0.2× 38 1.0k
David M. Nanus United States 13 442 1.3× 350 1.3× 31 0.2× 41 0.2× 58 0.4× 27 902
S Takai Japan 12 312 0.9× 135 0.5× 114 0.6× 23 0.1× 159 1.0× 21 744
Xin Shi China 10 401 1.2× 237 0.9× 62 0.3× 25 0.1× 92 0.6× 34 723
Daniel DiRenzo United States 15 478 1.4× 170 0.6× 102 0.5× 34 0.2× 157 1.0× 38 1.0k
C. Leann Hinkle United States 6 374 1.1× 302 1.1× 28 0.1× 193 1.0× 62 0.4× 6 809
Yasuhiko Akiyama Japan 13 160 0.5× 76 0.3× 209 1.0× 23 0.1× 58 0.4× 54 646

Countries citing papers authored by Hicham Lahlou

Since Specialization
Citations

This map shows the geographic impact of Hicham Lahlou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hicham Lahlou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hicham Lahlou more than expected).

Fields of papers citing papers by Hicham Lahlou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hicham Lahlou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hicham Lahlou. The network helps show where Hicham Lahlou may publish in the future.

Co-authorship network of co-authors of Hicham Lahlou

This figure shows the co-authorship network connecting the top 25 collaborators of Hicham Lahlou. A scholar is included among the top collaborators of Hicham Lahlou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hicham Lahlou. Hicham Lahlou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hofman, Paul, Pascal Puchois, Patrick Brest, Hicham Lahlou, & Daniel Simeon‐Dubach. (2020). Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry. Nature Medicine. 26(6). 809–810. 17 indexed citations
2.
Lahlou, Hicham, Virginie Sanguin‐Gendreau, Margaret C. Frame, & William J. Muller. (2012). Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo. Breast Cancer Research. 14(1). R36–R36. 23 indexed citations
3.
Lahlou, Hicham, Thomas Müller, Virginie Sanguin‐Gendreau, Carmen Birchmeier, & William J. Muller. (2012). Uncoupling of PI3K from ErbB3 Impairs Mammary Gland Development but Does Not Impact on ErbB2-Induced Mammary Tumorigenesis. Cancer Research. 72(12). 3080–3090. 21 indexed citations
4.
Lahlou, Hicham & William J. Muller. (2011). β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer. Breast Cancer Research. 13(6). 229–229. 81 indexed citations
5.
Najib, Souad, et al.. (2008). Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1. Cellular and Molecular Life Sciences. 65(19). 3110–3117. 26 indexed citations
6.
Lahlou, Hicham, Virginie Sanguin‐Gendreau, Dongmei Zuo, et al.. (2007). Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proceedings of the National Academy of Sciences. 104(51). 20302–20307. 169 indexed citations
7.
Guillermet‐Guibert, Julie, Hicham Lahlou, Stéphane Pyronnet, Corinne Bousquet, & Christiane Susini. (2005). Somatostatin receptors as tools for diagnosis and therapy: Molecular aspects. Best Practice & Research Clinical Gastroenterology. 19(4). 535–551. 34 indexed citations
8.
Lahlou, Hicham, Marjorie Fanjul, Lucien Pradayrol, Christiane Susini, & Stéphane Pyronnet. (2005). Restoration of Functional Gap Junctions through Internal Ribosome Entry Site-Dependent Synthesis of Endogenous Connexins in Density-Inhibited Cancer Cells. Molecular and Cellular Biology. 25(10). 4034–4045. 52 indexed citations
9.
Vaysse, Nicole, Hicham Lahlou, Géraldine Ferjoux, & Christiane Susini. (2005). Novel Therapeutic Targets for Somatostatin in Inflammatory Chronic Diseases. 4(1). 91–104. 4 indexed citations
10.
Bousquet, Corinne, Julie Guillermet‐Guibert, Fabienne Vernejoul, et al.. (2004). Somatostatin receptors and regulation of cell proliferation. Digestive and Liver Disease. 36. S2–S7. 40 indexed citations
11.
Lahlou, Hicham, Julie Guillermet‐Guibert, Fabienne Vernejoul, et al.. (2004). Molecular Signaling of Somatostatin Receptors. Annals of the New York Academy of Sciences. 1014(1). 121–131. 116 indexed citations
12.
Lahlou, Hicham, Nathalie Saint‐Laurent, Jean‐Pierre Estève, et al.. (2003). sst2 Somatostatin Receptor Inhibits Cell Proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 Activation. Journal of Biological Chemistry. 278(41). 39356–39371. 105 indexed citations
13.
Masri, Bernard, Hicham Lahlou, Honoré Mazarguil, Bernard Knibiehler, & Yves Audigier. (2002). Apelin (65–77) Activates Extracellular Signal-Regulated Kinases via a PTX-Sensitive G Protein. Biochemical and Biophysical Research Communications. 290(1). 539–545. 137 indexed citations
14.
Francès, Bernard, et al.. (2001). Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF. Regulatory Peptides. 98(1-2). 13–18. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026